SCHEMBL19745997

SCHEMBL19745997

Cc1ccc(S(=O)(=O)n2cnc3c(Cl)ncnc32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ ALDH3A1 P30838 2/20 0.48
▸ NOD1 Q9Y239 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ P2RX7 Q99572 2/20 0.40
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PTGS2 P35354 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ RAPGEF4 Q8WZA2 1/20 0.38
▸ CXCL8 P10145 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ NOD2 Q9HC29 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ PTGS1 P23219 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ FDPS P14324 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27902488 0.84 P2RX7 (0.44) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL27885510 0.82 LMNA (0.38) L3MBTL1ALDH3A1HTTP2RX7ALDH1A1
SCHEMBL19204899 0.82 P2RX7 (0.61) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL27885507 0.81 CYP1A2 (0.47) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL28802463 0.81 P2RX7 (0.47) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL19746470 0.80 P2RX7 (0.46) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL30752005 0.78 L3MBTL1 (0.52) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL1356181 0.78 L3MBTL1 (0.52) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL15408335 0.75 LMNA (0.41) L3MBTL1ALDH3A1NOD1POLBHTT
SCHEMBL23882189 0.75 L3MBTL1 (0.40) L3MBTL1ALDH3A1NOD1POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190127397-A1 Complexes for Nucleophilic, Radical, and Electrophilic Polyfluoroalkylation THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2019-05-02 — — US disclosed
WO-2017223406-A1 COMPLEXES FOR NUCLEOPHILIC, RADICAL, AND ELECTROPHILIC POLYFLUOROALKYLATION THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2017-12-28 — — WO disclosed
CN-102850355-A 9-sulfonyl-9H-purine derivatives, and preparation method and use thereof UNIV SICHUAN 2013-01-02 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127397-A1 Complexes for Nucleophilic, Radical, and Electrophilic Polyfluoroalkylation NBAS, PFAS, PCBP1 L3MBTL1 3127/4885ALDH3A1 2219/4885NOD1 2507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback